Pharmacy-based interdisciplinary screening for hypertensio
- Conditions
- Hypertention
- Registration Number
- DRKS00027497
- Lead Sponsor
- ABDA - Bundesvereinigung Deutscher Apothekerverbände e. V.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Informed consent
Exclusion Criteria
Diagnosis of hypertention, taking antihypertensive drugs (blood pressure lowering agents ATC codes C03, C07, C08, C09 incl. C04, C02 (including clonidine, moxonidine, doxazosin), C01 (nitrates)) or G04 (alpha-blockers), coffee, energy drinks or black tea up to 30 minutes before blood pressure measurement
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method • How many people can have their blood pressure measured in the participating study pharmacies in a period of max. 8 weeks?<br>• How many people without known hypertension are referred to the hypertension outpatient clinic because of elevated blood pressure values?<br>• How many of them take up the examination offer (make an appointment)?<br>• How many participants are diagnosed with hypertension (or another disease)?
- Secondary Outcome Measures
Name Time Method • Are the thresholds for referral to the hypertension outpatient clinic set correctly in terms of detection of hypertension?<br>• How many people with undetected hypertension can be identified with this concept?<br>• Can patient characteristics be identified that will allow future blood pressure screening in pharmacies to be more tailored to people with risk factors?